Sun Pharmaceutical Industries Limited — Updates, 16-03-2026: Press Release
16-03-2026 | 04:23 pm
16-03-2026 | 04:23 pm
Sun Pharma's ILUMYA sBLA for Psoriatic Arthritis treatment accepted by US FDA. This potential indication expansion by October 2026 could significantly boost ILUMYA's market and address an unmet need for psoriasis patients.
No comments yet. Be the first to comment!
All announcements from Sun Pharmaceutical Industries Limited
